Becton Dickinson & Co (WBO:BDX)
€ 210.4 -0.6 (-0.28%) Market Cap: 60.75 Bil Enterprise Value: 77.74 Bil PE Ratio: 37.36 PB Ratio: 2.48 GF Score: 82/100

Becton Dickinson and Co at JPMorgan Healthcare Conference Transcript

Jan 14, 2020 / 11:00PM GMT
Release Date Price: €241.3 (+0.47%)
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst

Good afternoon, everyone. I'm Robbie Marcus, the medical device analyst at JPMorgan. I'm happy to introduce the President and COO and incoming CEO of Becton, Dickinson, Tom Polen, for his first presentation at JPMorgan.

Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director

Great. Thank you, Robbie.

Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst

Thank you.

Thomas E. Polen
Becton, Dickinson and Company - President, CEO & Director

Okay. Thank you, Robbie. And as always, it's a pleasure to be here, and thanks, everyone, for joining us. As many of you know, I'm Tom Polen, BD's President and Chief Operating Officer, and in 2 weeks, I'll transition to my new role as the next CEO of BD. It's truly an honor to lead BD in such an exciting time, and I'm happy to be here to share our plans for BD's next phase of value creation.

Before I get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot